Exopolysaccharides isolated from hydrothermal vent bacteria can modulate the complement system

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Courtois, Anthony ^a,b,c   Berthou, Christian ^b   Guézennec, Jean ^a   Boisset, Claire ^a,d   Bordron, Anne ^b  

^a IFREMER   (France)

^b BREST UNIVERSITY HOSPITAL   (France)

^c Polymaris Biotechnology Chamber of Commerce and Industry ^*  (France)

^d CENTRE DE RECHERCHES SUR LES MACROMOLÉCULES VÉGÉTALES CERMAV CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; EXOPOLYSACCHARIDE; FUCOIDIN; GY 785; HE 800; UNCLASSIFIED DRUG; BACTERIAL POLYSACCHARIDE; COMPLEMENT;

ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT INHIBITION; COMPLEMENT SYSTEM; CONTROLLED STUDY; DEPOLYMERIZATION; DRUG MECHANISM; IMMUNOMODULATION; MOLECULAR WEIGHT; SULFATION; BACTERIA; CHEMISTRY; DRUG EFFECTS; HUMAN; HYDROTHERMAL VENT; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY;

BACTERIA; COMPLEMENT ACTIVATION; COMPLEMENT C1Q; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT SYSTEM PROTEINS; HUMANS; HYDROTHERMAL VENTS; IMMUNOMODULATION; MOLECULAR WEIGHT; POLYSACCHARIDES, BACTERIAL;

EID: 84899669159     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094965     Document Type: Article

References (48)

1. Cheng SC, Sprong T, Joosten LA, van der Meer JW, Kullberg BJ, et al (2012) Complement plays a central role in Candida albicans-induced cytokine production by human PBMCs. Eur J Immunol 42: 993-1004.
2. Hu W, Ge X, You T, Xu T, Zhang J, et al (2011) Human CD59 inhibitor sensitizes rituximab-resistant lymphoma cells to complement-mediated cytolysis. Cancer Res71: 2298-2307.
3. Roumenina LT, Sène D, Radanova M, Blouin J, Halbwachs-Mecarelli L, et al (2011) Functional complement C1q abnormality leads to impaired immune complexes and apoptotic cell clearance. J. Immunol 187: 4369-4373.
4. Markiewski MM, Lambris JD (2007) The Role of Complement in Inflammatory Diseases From Behind the Scenes into the Spotlight. Am J Pathol 171: 715-727.
5. Muller-Eberhard HJ (1969) Complement. Annu Rev Biochem 38: 389-414.
6. Muller-Eberhard HJ (1988) Molecular organization and function of the complement system. Annu. Rev. Biochem 57: 321-347.
7. Makrides SC (1998) Therapeutic inhibition of the complement system. Pharmacol. Rev 50: 59-87.
8. Hosszu KK, Valentino A, Ji Y, Matkovic M, Pednekar L, et al (2012) Cell surface expression and function of the macromolecular C1 complex on the surface of human monocytes. Front Immunol 3: 38.
9. Triolo G, Accardo-Palumbo A, Sallì L, Ciccia F, Ferrante A, et al (2003) Impaired expression of erythrocyte glycosyl-phosphatidylinositol-anchored membrane CD59 in patients with psoriatic arthritis. Relation to terminal complement pathway activation. Clin. Exp. Rheumatol 21: 225-228.
10. Gadjeva M, Thiel S, Jensenius JC (2001) The mannan-binding-lectin pathway of the innate immune response. Curr. Opin. Immunol 13: 74-78.
11. Hodoniczky J, Zheng YZ, James DC (2005) Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro. Biotechnol 21: 1644-1652.
12. Rudd PM, Wormald MR, Dwek RA (2004). Sugar-mediated ligand-receptor interactions in the immune system. Trends Biotechnol 22: 524-530.
13. Colliec Jouault S, Chevolot L, Helley D, Ratiskol J, Bros A, et al (2001) Characterization, chemical modifications and in vitro anticoagulant properties of an exopolysaccharide produced by Alteromonas infernus. Biochim Biophys Acta 1528; 141-51.
14. Nwodu UU, Green E, Okoh AL (2012) Bacterial exopolysaccharides: functionaliy and prospects. Int. J.Mol. Sci 13(11): 14002-14015.
15. Khalikova TA, Korolenko TA, Zhanaeva SY, Kaledin VI, Kogan G, et al (2006) Enhancing effect of new biological response modifier sulfoethylated (1-.3)- beta-D-glucan on antitumor activity of cyclophosphamide in the treatment of experimental murine leukoses. Exp. Oncol. 28: 308-313.
16. Okutani K (1984) Antitumor and immunostimulant activities of polysaccharides produced by a marine bacterium of the genus vibrio. Bull. Jap. Soc.Sci. Fish 50: 1035-1037.
17. Makino S, Ikegami S, Kano H, Sashihara T, Sugano H, et al (2006) Immunomodulatory effects of polysaccharides produced by Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. J Dairy Sci 89: 2873-81.
18. Arena A, Maugeri TL, Pavone B, Iannello D, Gugliandolo C, et al (2006). Antiviral and immunoregulatory effect of a novel exopolysaccharide from a marine thermotolerant Bacillus licheniformis. Int Immunopharmacol 6: 8-13.
19. Tzianabos AO (2000) Polysaccharide immunomodulators as therapeutic agents: structural aspects and biologic function. Clin Microbiol Rev 13: 523-533.
20. Zanchetta P, Lagarde N, Guezennec J (2003) Systemic effects on bone healing of a new hyaluronic acid-like bacterial exopolysaccharide. Calcif Tissue Int 73: 232-236.
21. Zanchetta P, Lagarde N, Guezennec J (2003) A new bone-healing material: a hyaluronic acid-like bacterial exopolysaccharide. Calcif. Tissue Int 72: 74-79.
22. Kwang-Soon S, Kwang-Won Y Hyun-Kyung L, Ho L, Won-Dai C, et al (2007) Production of anti-complementary exopolysacharides from submerged culture of Flammulina velutipes. Food Technol. Biotechnol 45: 319-326.
23. Raguénès GH, Peres A, Ruimy R, Pignet P, Christen R, et al (1997) Alteromonas infernus sp. nov., a new polysaccharide-producing bacterium isolated from a deep-sea hydrothermal vent. J. Appl. Microbiol 82: 422-430.
24. Raguénès G, Christen R, Guezennec J, Pignet P, Barbier G (1997) Vibrio diabolicus sp. nov., a new polysaccharide-secreting organism isolated from a deepsea hydrothermal vent polychaete annelid, Alvinella pompejana. Int. J. Syst. Bacteriol 47: 989-995.
25. Mulloy B, Mourão PA, Gray E (2000) Structure/function studies of anticoagulant sulphated polysaccharides using NMR. J. Biotechnol 77; 123-135.
26. Rougeaux H, Kervarec N, Pichon R, Guezennec J (1999) Structure of the exopolysaccharide of Vibrio diabolicus isolated from a deep-sea hydrothermal vent. Carbohydr. Res 322: 40-45.
27. Talmont F, Fournet B (1991) Isolation and characterization of methylated sugars from the tube of the hydrothermal vent tubiculous annelid worm Alvinella pompejana. FEBS Lett 281: 55-58.
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
29. Lijour Y, Gentric E, Deslandes E (1994) Estimation of the sulfate content of hydrothermal vent bacterial polysaccharides by Fourier transform infrared spectroscopy. Anal. Biochem 220; 244-248.
30. Nardella A, Chaubet F, Boisson-Vidal C, Blondin C, Durand P, et al Anticoagulant low molecular weight fucans produced by radical process and ion exchange chromatography of high molecular weight fucans extracted from the brown seaweed Ascophyllum nodosum. Carbohydr Res 289: 201-208.
31. Maiga-Revel O, Chaubet F, Jozefonvicz J (1997). New investigations on heparinlike derivatized dextrans: CMDBS, synergistic role of benzylamide and sulfate substituents in anticoagulant activity. Carbohydr. Polymers 32: 89-93.
32. Kazatchkine M, Hauptmann G, Nydegger U (1985) Dosages hémolytiques des composants du Complément. Société française d'Immunologie: Paris, France: 15-44.
33. Lutz HU, Stammler P, Jelezarova E, Nater M, Spä th PJ (1996) High doses of immunoglobulin G attenuate immune aggregate-mediated complement activation by enhancing physiologic cleavage of C3b in C3bn-IgG complexes. Blood 88: 184-193.
34. Caldwell EE, Andreasen AM, Blietz MA, Serrahn JN, VanderNoot V, et al (1999) Heparin binding and augmentation of C1 inhibitor activity. Arch Biochem Biophys 361 : 215-222.
35. Courtois A, Simon-Colin C, Boisset C, Berthou C, Deslandes E, et al (2008). Floridoside extracted from the red alga Mastocarpus stellatus is a potent activator of the classical complement pathway. Mar. Drugs 6: 407-417.
36. Galili U (2001). The alpha-gal epitope (Gal alpha 1-3Gal beta 1-4GlcNAc-R) in xenotransplantation. Biochimie 83: 557-563.
37. Good AH, Cooper DK, Malcolm AJ, Ippolito RM, et al (1992) Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 24: 559-562.
38. Courtois C, Gac-Breton S, Berthou C, Guezennec J, Bordron, et al (2012) Complement dependent cytotoxicity activity of therapeutic antibody fragments is acquired by immunogenic glycan coupling. Electron. J Biotechnol 15: 1-11.
39. Yamamoto F (2004) Review: ABO blood group system-ABH oligosaccharide antigens, anti-A and anti-B, A and B glycosyltransferases, and ABO genes. Immunohematol 20: 3-22.
40. Vukajlovich SW(1986). Antibody-independent activation of the classical pathway of human serum complement by lipid A is restricted to re-chemotype lipopolysaccharide and purified lipid A. Infect. Immun 53: 480-485.
41. Fabiana Alberto M, Giaquinta Romero D, Lazzari M, Calabrese GC. Antithrombotic and anticomplementary properties of a very low molecular mass dermatan sulfate. Thromb Res 122: 109-116.
42. Tissot B, Daniel R (2003) Biological properties of sulfated fucans: the potent inhibiting activity of algal fucoidan against the human compliment system. Glycobiology 13: 29G-30G.
43. Blondin C, Chaubet F, Nardella A, Sinquin C, Jozefonvicz J (1996) Relationships between chemical characteristics and anticomplementary activity of fucans. Biomaterials 17: 597-603.
44. Tissot B, Gonnet F, Iborra A, Berthou C, Thielens N, et al (2005) Mass spectrometry analysis of the oligomeric C1q protein reveals the B chain as the target of trypsin cleavage and interaction with fucoidan. Biochemistry 44: 2602-2609.
45. Kirschfink M, Blase L, Engelmann S, Schwartz-Albiez R (1997) Secreted chondroitin sulfate proteoglycan of human B cell lines binds to the complement protein C1q and inhibits complex formation of C1. J Immunol 158: 1324-1331.
46. Jokiranta TS, Westin J, Nilsson UR, Nilsson B, Hellwage J, et al (2001) Complement C3b interactions studied with surface plasmon resonance technique. Int. Immunopharmacol 1: 495-506.
47. Caldwell EE, Andreasen AM, Blietz M.A, Serrahn JN, VanderNoot V, et al (1999) Heparin binding and augmentation of C1 inhibitor activity. Arch. Biochem. Biophys 361: 215-222.
48. McDonnell JM (2001) Surface plasmon resonance: towards an understanding of the mechanisms of biological molecular recognition. Curr. Opin. Chem.Biol 5: 572-577.